Heidrun Bosch‐Traberg

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

Vlado Perkovic, Katherine R. Tuttle, Peter Rossing et al. · New England Journal of Medicine · 2024 · 1.5K citations

Medicine, Pharmacology, Pharmacotherapy +17

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

Peter Rossing, Florian M.M. Baeres, George L. Bakris et al. · Nephrology Dialysis Transplantation · 2023 · 237 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial

Melanie J. Davies, Stephen C. Bain, Stephen L. Atkin et al. · Diabetes Care · 2015 · 228 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

Johannes F.E. Mann, Peter Rossing, George L. Bakris et al. · Nature Medicine · 2024 · 154 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial

Michael A. Nauck, Manfredi Rizzo, A.B. Johnson et al. · Diabetes Care · 2016 · 143 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17